Aptevo Therapeutics Inc.APVONASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank17
3Y CAGR-5.2%
5Y CAGR-3.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-5.2%/yr
vs -16.2%/yr prior
5Y CAGR
-3.3%/yr
Consistent
Acceleration
+11.0pp
Accelerating
Percentile
P17
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.81M | +15.5% |
| 2024 | $10.22M | -13.1% |
| 2023 | $11.77M | -15.2% |
| 2022 | $13.87M | -5.6% |
| 2021 | $14.70M | +5.4% |
| 2020 | $13.95M | -0.1% |
| 2019 | $13.96M | -50.4% |
| 2018 | $28.13M | -18.6% |
| 2017 | $34.58M | -10.6% |
| 2016 | $38.67M | - |